Analyst Insight: Radically changing market conditions in the global pharmaceuticals industry are creating volatility in supply and demand, as well as affecting customer service levels and costs. Pharma companies are also faced with impending margin pressure from generics. In this environment, pharma executives are looking to improve efficiencies, understand emerging market customers and be better prepared to meet financial objectives. Supply chain analytics provides pharma supply chain executives with powerful tools to maintain a competitive edge. – Jay Welsh, Principal, and Srihari Rangarajan, Manager, Ernst & Young LLP